We gather useful links to news on the thousands of companies listed in the directory either directly from the company or independently from authoritative publicly available sources e.g. industry newspapers, journals and websites. You can use this news database to search these links. Search either by the name of company or by country/place or key word or combination thereof.
Save This Search | View as Grid | Order by Recently Added | Order by Company Name
Indena SpA 17 May 2019
After demonstrating its activity, efficacy and safety profile in the field of sports nutrition, a pilot non-interaction study confirms the high tolerability of Quercefit™ in individuals assuming antiplatelet agents, anticoagulants or living with diabetes.
Pfizer 01 May 2019
Strong vaccine and cancer drug sales help Merck top earnings expectations and send its shares higher
PolyPeptide Laboratories 27 Apr 2019
Vetter Pharma International GmbH 26 Apr 2019
In 2018, a record of 55 submitted drugs received approval from the FDA. Key to this achievement was a focus on reaching clinical end points as well as compliance with good and high-quality manufacturing practice. Well-orchestrated cGMP manufacturing can help avoid manufacturing issues primarily in the clinical phases as well as in discussing potential projects with partners or key stakeholders.
Actex Pharma Services 26 Apr 2019
WuXi Biologics 25 Apr 2019
This week, the FDA approved Trogarzo (ibalizumab-uiyk), the first HIV therapy with a novel mechanism of action in more than 10 years and the first drug developed by Taiwan-based TaiMed Biologics. It also represents a first for WuXi Biologics, the Chinese company that will produce it at a biologics plant near Shanghai.
WuXi Biologics 25 Apr 2019
Production of HIV drug Trogarzo is now approved at the Wuxi facility
Cambrex Profarmaco 25 Apr 2019
East Rutherford, NJ – March 14, 2019 – Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that it has completed the expansion of a new 150m2 research and development laboratory at its site in Paullo, Milan, Italy. In addition, Cambrex has installed a new 12,000 liter reactor into one of its cGMP manufacturing facilities at…
Cambrex 25 Apr 2019
East Rutherford, NJ – April 10, 2019 – Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that it had completed the construction of a $24 million highly potent API (HPAPI) manufacturing facility at its site in Charles City, IA. The 6,000 sq. ft. facility is currently undergoing validation and will…
Avidity Biosciences 25 Apr 2019
Lilly and Avidity Biosciences Announce Licensing and Research Collaboration
Almac Sciences 25 Apr 2019
Currently employing over 150 highly skilled analysts working in GMP / GLP environments from its 3 locations in Craigavon, UK; Athlone, Ireland; and Souderton, Pennsylvania, North America, Almac is positioned as the partner of choice with significant experience in a wide range of analytical services.
Poseida Therapeutics Inc 24 Apr 2019
SAN DIEGO, April 22, 2019 — Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today announced closing of a Series C financing round, raising $142 million led by a $75 million equity investment from Novartis Pharma AG, and joined by several new investors including Aisling Capital Management, Pentwater Capital Management, Perceptive…
Amryt Pharma 24 Apr 2019
Lojuxta revenues driven by UK, France reimbursement approval
Irish pharmaceutical company Amryt said its revenues rose 13.3 per cent in 2018 to €14.5 million and the strong momentum continued into the first quarter of this year as revenues from its main drug Lojuxta picked up.
Fusion Antibodies plc 24 Apr 2019
Orders and revenues rise in Belfast-based firm in final six months of financial year. Revenues for the second half of the year rose to £1.5 million (€1.7 million), compared with £700,000 in the first six months of the year, and £1.3 million for the same period a year earlier.
Schott Glass AG 23 Apr 2019
SCHOTT Invests $1B in Pharmaceutical Packaging Dr. Heinricht of SCHOTT discusses the investment, growth markets, and how pharma and biopharma needs are changing
Paragon Bioservices 22 Apr 2019
Facility Expands collaboration in manufacturing design and operation with Sarepta Therapeutics
Schott Glass AG 22 Apr 2019
As part of its global growth strategy, the technology group SCHOTT is investing BRL 50 million in its pharmaceutical tubing production in Rio de Janeiro in the next two years. The invest covers the latest update of the company’s perfeXion® process – a 100 percent on-line inspection system, which examines every single tube – as well as implementing state-of-the-art production technology in glass-melting furnaces. It follows a previous modernization project, which has…
MS Pharma 19 Apr 2019
MS Pharma, a fast growing pharmaceutical company based in Jordan and operating across the Middle East, Turkey and Africa, announced today that it has entered into an agreement to acquire 100% of the outstanding shares in Genepharm, a leading European pharmaceutical company. Genepharm’s senior management will remain with the business and help guide the company through the next phase of its growth. The transaction is expected to close by the end of April.
